Trials / Completed
CompletedNCT00725777
Treatment of Non-falciparum Malaria
Efficacy and Safety of Artemether Lumefantrine Combination Therapy for the Treatment of Malaria Due to Plasmodium Ovale, Plasmodium Malariae, and Mixed Plasmodium Infections in Gabon
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Albert Schweitzer Hospital · Academic / Other
- Sex
- All
- Age
- 6 Months – 60 Years
- Healthy volunteers
- Not accepted
Summary
Patients with non-falciparum infection will be given artemether-lumefantrine for three days and will be followed up for 28 days. Besides efficacy and safety evaluations a substudy on immunology will be performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | artemether-lumefantrine | Standard artemether-lumefantrine treatment |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2011-12-01
- Completion
- 2012-02-01
- First posted
- 2008-07-30
- Last updated
- 2012-02-17
Locations
1 site across 1 country: Gabon
Source: ClinicalTrials.gov record NCT00725777. Inclusion in this directory is not an endorsement.